SCHEMBL14985489

SCHEMBL14985489

ICCNc1ccncc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.46
FDPS P14324 1/20 0.41
F2 P00734 6/20 0.41
ADRA2B P18089 1/20 0.41
KCNH2 Q12809 1/20 0.40
GRIN2B Q13224 1/20 0.40
MDM2 Q00987 1/20 0.38
RAD52 P43351 1/20 0.37
HDAC8 Q9BY41 1/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
KDM4E B2RXH2 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
BCHE P06276 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1282816 0.81 CTSD (0.46) CTSDFDPSF2ADRA2BKCNH2
SCHEMBL23336901 0.80
SCHEMBL16596248 0.76 CTSD (0.46) CTSDFDPSF2ADRA2BKCNH2
SCHEMBL5495415 0.76 CTSD (0.46) CTSDFDPSF2ADRA2BKCNH2
SCHEMBL7054279 0.76 LIMK1 (0.51) CTSDFDPSF2ADRA2BKCNH2
SCHEMBL714498 0.76 CTSD (0.46) CTSDFDPSF2ADRA2BKCNH2
SCHEMBL1678422 0.76 ADRA2B (0.49) CTSDFDPSF2ADRA2BKCNH2
SCHEMBL3223115 0.76 CTSD (0.46) CTSDFDPSF2ADRA2BKCNH2
SCHEMBL6032869 0.76 CYP2C19 (0.50) CTSDF2RAD52ALDH1A1KDM4E
SCHEMBL13552314 0.75 ALDH1A1 (0.64) CTSDMAPTALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3153023-A1 BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE Intellikine, LLC (US) 2017-04-12 EP disclosed
EP-2705181-B1 COMBINATION PHARMACEUTICAL COMPOSITIONS AND USES THEREOF INTELLIKINE LLC (US) 2016-12-21 EP disclosed
WO-2014151147-A1 COMBINATION OF KINASE INHIBITORS AND USES THEREOF INTELLIKINE, LLC (US) 2014-09-25 WO disclosed
WO-2013078440-A2 ENHANCED TREATMENT REGIMENS USING MTOR INHIBITORS INTELLIKINE, LLC (US) 2013-05-30 WO disclosed